From: Metabolic Syndrome as a Cardiovascular Disease Risk Factor: Patients Evaluated in Primary Care
CVD complication | B exponential = Odds Ratio(95%CI)* |
---|---|
All complications | Females;OR = 2.26(1.48–3.47) |
Metabolic syndrome (WHO criteria);OR = 3.48(2.26–5.37) | |
Metabolic syndrome (IDF criteria);OR = 2.28(1.84–4.90) | |
Coronary | Metabolic syndrome (WHO criteria);OR = 3.10(1.48–6.49) |
Metabolic syndrome (IDF criteria);OR = 1.96(1.15–4.89) | |
Cerebrovascular | Females;OR = 2.46(1.06–5.37) |
Metabolic syndrome (NCEP criteria);OR = 2.59(1.26–5.27) | |
Peripheral vascular | Females; OR = 3.61(1.72–7.55) |
Metabolic syndrome (WHO criteria);OR = 2.26(1.11–4.61) | |
Metabolic syndrome (NCEP criteria);OR = 2.74(1.82–5.33) | |
Retinopathy | Metabolic syndrome (NCEP criteria);OR = 2.80(1.07–7.34) |
Metabolic syndrome (IDF criteria);OR = 3.63(2.27–7.94) | |
Nephropathy | Females; OR = 2.97(1.32–6.66) |
Metabolic syndrome (WHO criteria); OR = 11.78(4.91–28.3) | |
Metabolic syndrome (IDF criteria);OR = 3.51(2.07–12.2) | |
Neuropathy | Metabolic syndrome (NCEP criteria);OR = 12.41(1.44–106.9) |